FerringUSA

Latest News

December 09, 2011

EXPERTS LAUNCH THE ALLIANCE FOR FERTILITY PRESERVATION AT THE INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION'S 2ND WORLD CONGRESS

Miami Beach, FL Dec. 9, 2011 – As hundreds of scientists gathered today to discuss fertility preservation...

November 22, 2011

FERRING PHARMACEUTICALS TO DEVELOP MAJOR CORPORATE CENTER IN PARSIPPANY, NEW JERSEY

Parsippany, NJ —Oct. 21, 2011 — /PRNewswire/ – Switzerland-based Ferring Pharmaceuticals...

October 21, 2011

FDA APPROVES LONGER DURATION EFFICACY AND SAFETY FOR EUFLEXXA®

Parsippany, NJ —Oct. 21, 2011 — On Oct. 11, 2011, the FDA approved a labeling supplement...

October 20, 2011

FERRING ACQUIRES CYTOKINE PHARMASCIENCES INC.

10/20/2011 - Ferring has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its UK subsidiary...

October 17, 2011

RETROSPECTIVE ANALYSIS EVALUATES THE EFFECT OF LYSTEDA® ON THE NUMBER OF SLEEP INTERRUPTIONS FOR WOMEN WITH CYCLIC HEAVY MENSTRUAL BLEEDING

Findings presented at Nurse Practitioners in Women’s Health 14th Annual Premier Women’s HealthCare...

Show All

The Ferring USA Product Line


Fertility_animated Euflexxa_home Degarelix_home
Ferringusa_lysteda Gastroenterology_home

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

Non-US visitors, please visit our international site at www.ferring.com.

©2008-2012 Ferring Pharmaceuticals